Chemical Modulation of the Siah-1 Pathway
Chemical Modulation of the Siah-1 Pathway
批准号:
7694153
负责人:
JOHN C REED
金额:
$2.5万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-15 至 2010-03-31
关键词:
ApoptosisBindingBinding SitesBiologicalBiological AssayBiologyBreast Cancer CellCancer cell lineCell Cycle ArrestCell Cycle RegulationCell LineCell divisionCell physiologyCellsChemicalsChemistryComplexConsensusCytokinesisDNA DamageDataDegradation PathwayDevelopmentEngineeringEnzymesEventExcisionFamilyFibroblastsFluorescence PolarizationGenesGoalsHumanHypoxiaLaboratoriesLibrariesLigandsLinkLuciferasesMalignant NeoplasmsMammalian CellMediatingMediator of activation proteinMessenger RNAMethodologyMethodsMitoticMixed Function OxygenasesMusMutationN-terminalPathway interactionsPeptidesPlasmidsPlayPolyubiquitinPost-Translational Protein ProcessingProcessProductionProlineProtein FamilyProteinsProteolysisProviderRecoveryReporter GenesReportingResearchRoleScreening procedureSerumSiah-1 proteinSignal PathwaySignal TransductionStructure-Activity RelationshipTCF Transcription FactorTP53 geneTertiary Protein StructureTranscription CoactivatorTubulinTumor SuppressionTumor Suppressor ProteinsUbiquitinUbiquitin-Conjugating EnzymesUbiquitinationUnited States National Institutes of HealthVav guanine-nucleotide exchange factorWorkbasecell growthcell transformationcellular engineeringcheminformaticshigh throughput screeninghuman NCOR1 proteinmalignant stomach neoplasmmembermetabotropic glutamate receptor 4multicatalytic endopeptidase complexoverexpressionpancreatic neoplasmpromoterprotein degradationprotein protein interactionpublic health relevanceresponsesmall molecule librariestherapy resistanttooltumortumor growthubiquitin ligaseubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Proteasomal degradation typically requires post-translational modification of target proteins with K48-linked polyubiquitin chains. This process of protein proteolysis plays a key role in normal cellular function. The E3 ubiquitin ligase, Siah-1, facilitates the transfer of ubiquitin to its substrate proteins destined for degradation by way of its RING domain. Siah-1 is a member of a family of highly conserved RING domain proteins, which regulate a variety of cellular functions, including cell cycle arrest, tumor suppression, and apoptosis through the -catenin degradation pathway. Siah-1 has also been identified as a p53-inducible gene, functionally linking it to an important tumor suppressor. Chemical modulators of the Siah-1 pathway would provide powerful research tools for elucidating the roles of this signaling pathway in cancer development and progression. In this proposal, we describe the development of a High Throughput Screening (HTS) assay based upon fluorescence polarization, and utilizing a peptide ligand of Siah-family proteins with an attached flurochrome. This fluorescence polarization assay (FPA) forms the basis for a high-throughput competitive displacement assay that we have optimized for chemical library screening. We propose to screen the NIH compound library using this HTS assay. Additional downstream assays provided by the assay provider will be performed for deconvoluting hits. We expect to obtain candidate compounds for Structure Activity Relationship (SAR) studies to be performed for a prototypical RING- containing protein, Siah-1. Together, these efforts will result in validated chemical probes for studying the biology of Siah-family E3 ligases in a variety of biological settings.
PUBLIC HEALTH RELEVANCE: Our goal is to identify chemicals capable of modulating the Siah-1 proteasomal degradation pathway. Through its activity as an ubiquitin ligase, this signaling pathway helps to regulate a variety of cellular events, including cell cycle arrests, tumor suppression, and apoptosis. Chemical modulators of the Siah-1 pathway will provide powerful research tools for studying pathways involved in human cancer development, progression, and resistance to therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IAP Family Proteins and Cancer
-
批准号:8221594
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2012
-
负责人:JOHN C REED
-
依托单位:
Molecular Inhibition of Apoptosis Inhibitors
-
批准号:8235333
-
项目类别:
-
资助金额:$47.5万
-
财政年份:2011
-
负责人:JOHN C REED
-
依托单位:
Chemical Inhibitors of Autophagins for Autophagy modulation
-
批准号:8099787
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2010
-
负责人:JOHN C REED
-
依托单位:
Innate Immunity and HIV Restriction
-
批准号:8013192
-
项目类别:
-
资助金额:$97.63万
-
财政年份:2010
-
负责人:JOHN C REED
-
依托单位:
Chemical Inhibitors of Autophagins for Autophagy modulation
-
批准号:7929409
-
项目类别:
-
资助金额:$4.78万
-
财政年份:2010
-
负责人:JOHN C REED
-
依托单位:
Virulence Mechanisms of Viral Bcl-2 Homologs
-
批准号:8197123
-
项目类别:
-
资助金额:$47.75万
-
财政年份:2010
-
负责人:JOHN C REED
-
依托单位:
Virulence Mechanisms of Viral Bcl-2 Homologs
-
批准号:8026437
-
项目类别:
-
资助金额:$47.75万
-
财政年份:2010
-
负责人:JOHN C REED
-
依托单位:
Yeast-based HTS Assay Technologies for Proteases
-
批准号:7655951
-
项目类别:
-
资助金额:$42.98万
-
财政年份:2009
-
负责人:JOHN C REED
-
依托单位:
Yeast-based HTS Assay Technologies for Proteases
-
批准号:8033736
-
项目类别:
-
资助金额:$46.8万
-
财政年份:2009
-
负责人:JOHN C REED
-
依托单位:
Yeast-based HTS Assay Technologies for Proteases
-
批准号:8212269
-
项目类别:
-
资助金额:$46.8万
-
财政年份:2009
-
负责人:JOHN C REED
-
依托单位:
Yeast-based HTS Assay Technologies for Proteases
-
批准号:7759564
-
项目类别:
-
资助金额:$47.27万
-
财政年份:2009
-
负责人:JOHN C REED
-
依托单位:
Countermeasures for Bioterroism Targeting Cellular Host Factors
-
批准号:8082738
-
项目类别:
-
资助金额:$86.71万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Small Molecule Antagonists of IAPs Based on Mimicking SMAC
-
批准号:7737128
-
项目类别:
-
资助金额:$12.28万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Administrative Core
-
批准号:7737129
-
项目类别:
-
资助金额:$1.86万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Sanford-Burnham Center for Chemical Genomics
-
批准号:8142967
-
项目类别:
-
资助金额:$1675.25万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Countermeasures for Bioterroism Targeting Cellular Host Factors
-
批准号:8259775
-
项目类别:
-
资助金额:$83.78万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Countermeasures for Bioterroism Targeting Cellular Host Factors
-
批准号:7455399
-
项目类别:
-
资助金额:$76.0万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Countermeasures for Bioterroism Targeting Cellular Host Factors
-
批准号:7877961
-
项目类别:
-
资助金额:$75.25万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Burnham Center for Chemical Genomics
-
批准号:7938917
-
项目类别:
-
资助金额:$1680.82万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
Burnham Center for Chemical Genomics
-
批准号:7683049
-
项目类别:
-
资助金额:$1617.27万
-
财政年份:2008
-
负责人:JOHN C REED
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: